GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

As global regulators rethink tobacco control strategies, the U.S. FDA’s move toward a “chain of risk” framework has sparked ...

Janus Henderson Absolute Return Income Opportunities Fund returned 2.35% and the ICE BofA US 3M Trsy Bill TR USD returned ...

After months of anticipation, the Absolute Universe’s Joker has finally stepped out of the shadows, ending his long stretch of lurking in the background of Absolute Batman and showcasing that horrific ...

The new release date of Absolute Batman #14, along with the reason for its delay, has finally been revealed. Absolute Batman #14 comes after Absolute Batman #13, which dropped on October 8, 2025. The ...

Batman on the cover of Absolute Batman #1 - Marcos Martin/DC Comics "Absolute Batman" has hit the comic book world like a bat-shaped battle axe. Created by writer Scott Snyder and artist Nick Dragotta ...

Background Recent cardiovascular risk equations from the USA and United Kingdom use routinely collected electronic medical records (EMRs), while current equations used in Australia (AusCVDRisk) have ...

A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned that although ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook And something is. Despite six of the seven founding Justice League members having a title set in ...

(RTTNews) - Amgen (AMGN) announced detailed findings from its Phase 3 VESALIUS-CV clinical trial, revealing that Repatha (evolocumab) significantly reduces major adverse cardiovascular events (MACE) ...

NEW ORLEANS, LA—A PCSK9 inhibitor used on top of lipid-lowering therapy, including a high-intensity statin, significantly cuts the risk of major adverse cardiovascular events compared with placebo ...

Background: Elevated lipoprotein(a) [Lp(a)] is a presumed causal risk factor for coronary heart disease (CHD). Estimating the absolute CHD risk reduction with potential Lp(a) lowering using real-world ...